Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar, +614

The Lancet Neurology

Multicentre StudyPharmacologyMedicineMyasthenia GravisNeuromuscular Blockade +1

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu, +213

The Lancet Neurology

MedicineGeneralised Myasthenia Gravis

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

Enrico Millefiorini, Claudio Gasperini, Carlo Pozzilli, +10

Journal of Neurology

Relapsing-remitting Multiple SclerosisNeurological DisorderMedicineClinical NeurologyClinical Trials +6

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven, +147

The Lancet Neurology

Subcutaneous ImmunoglobulinAutoimmune DiseaseChronic InflammatoryMaintenance TreatmentImmunotherapy +10

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban, +343

The Lancet Neurology

Early neurologic complications following allogeneic bone marrow transplant for leukemia

Giovanni Antonini, V. Ceschin, Stefania Morino, +5

Neurology

HEALTH-RELATED QUALITY OF LIFE IN MYOTONIC DYSTROPHY TYPE 1 AND ITS RELATIONSHIP WITH COGNITIVE AND EMOTIONAL FUNCTIONING

Giovanni Antonini, Federica Soscia, Franco Giubilei, +5

Journal of Rehabilitation Medicine

Peripheral nerve ultrasound changes in CIDP and correlations with nerve conduction velocity

Antonella Di Pasquale, Stefania Morino, Simona Loreti, +3

Neurology

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi, +562

Neurology

Sensory involvement in spinal-bulbar muscular atrophy (Kennedy's disease)

Giovanni Antonini, Francesca Gragnani, A. Romaniello, +5

Muscle & Nerve